Daniel S. Graciaa

机构：Emory University, HOPE Clinic · ORCID：0000-0002-9484-8488

发表论文 45 篇 · 总被引 659 次 · h-index 11

代表论文

• Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial (2023 · Nature Medicine · 被引 57)
• Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants (2023 · npj Vaccines · 被引 34)
• SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses (2022 · medRxiv · 被引 30)
• Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults (2023 · JAMA Network Open · 被引 23)
• Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection (2022 · The Journal of Infectious Diseases · 被引 22)
• Risk of COVID-19 after natural infection or vaccination (2023 · EBioMedicine · 被引 14)